Close

UPDATE: Prothena Corp (PRTA) PT Raised to $35 at Oppenheimer on New Birtamimab Registrational Study

February 2, 2021 5:45 AM EST Send to a Friend
(Updated - February 2, 2021 8:40 AM EST)

Oppenheimer analyst Jay Olson raised the price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login